OMIC Announces 2020 Dividend Credit and 2020 Rate Readjustment
Each year, OMIC’s Board and
Executive Staff review OMIC’s rates to ensure we remain one of the
strongest companies in the industry. We are pleased to announce
that, due to continued favorable development on previously reported
claims, OMIC has declared a 15% dividend to be applied as a premium
credit in 2020 on physician renewal policies. ...
BULLETIN BOARD:
Recent FDA recommendation for voluntary recall related to AmEx Pharmacy products
AVASTIN Shortage
Americans with Disabilities Act – Patients and Your Duties
EYE ON OMIC:
OMIC forms partnerships with private equity organizations
Although the vast majority of OMIC's physician
policyholders are not currently employed by practices owned
and operated by private equity (PE) groups, we recognize this
is an emerging trend in entity ownership within the ophthalmic
community. While it is impossible to fully understand how these
organizations will impact the future of ophthalmic practice, we
have engaged with PE stakeholders, demonstrating how...
Marketing > Directory
General Questions:
(800) 562-6642 (Press 7)
Request Application Kit:
(800) 562-6642 (Press 661)
Media Inquiries:
(800) 562-6642 (ext 654)
General Questions:
(800) 562-6642 (Press 7)
Request Application Kit:
(800) 562-6642 (Press 661)
Media Inquiries:
(800) 562-6642 (ext 654)
Recent Articles
Raindrop Near Vision Inlay Recalled
Allergan Voluntary Recall of OZURDEX
UPCOMING EVENTS:
